{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:58Z","timestamp":1707525178550},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,9]]},"DOI":"10.7759\/cureus.43196","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T12:27:13Z","timestamp":1691584033000},"source":"Crossref","is-referenced-by-count":0,"title":["The Management of Motor Neuropathy With Plasmapheresis in a Patient With Acute Porphyria: A Case Report"],"prefix":"10.7759","author":[{"given":"Umar","family":"Maqbool","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Maqbool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajeeha","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Arsal","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2014.00039","article-title":"Acute hepatic porphyria","volume":"3","author":"Bissell DM","year":"2015","unstructured":"Bissell DM, Wang B. Acute hepatic porphyria. J Clin Transl Hepatol. 2015, 3:17-26. 10.14218\/JCTH.2014.00039","journal-title":"J Clin Transl Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.03.002","article-title":"Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)","volume":"128","author":"Bonkovsky HL","year":"2019","unstructured":"Bonkovsky HL, Dixon N, Rudnick S. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Mol Genet Metab. 2019, 128:213-8. 10.1016\/j.ymgme.2019.03.002","journal-title":"Mol Genet Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30936","article-title":"EXPLORE: a prospective, multinational, natural history study of patients with acute hepatic porphyria with recurrent attacks","volume":"71","author":"Gouya L","year":"2020","unstructured":"Gouya L, Ventura P, Balwani M, et al.. EXPLORE: a prospective, multinational, natural history study of patients with acute hepatic porphyria with recurrent attacks. Hepatology. 2020, 71:1546-58. 10.1002\/hep.30936","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-0040584-z","article-title":"Clinical features predictive of a poor prognosis in acute porphyria","volume":"251","author":"Pischik E","year":"2004","unstructured":"Pischik E, Bulyanitsa A, Kazakov V, Kauppinen R. Clinical features predictive of a poor prognosis in acute porphyria. J Neurol. 2004, 251:1538-41. 10.1007\/s00415-0040584-z","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.05.010","article-title":"Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias","volume":"128","author":"Dixon N","year":"2019","unstructured":"Dixon N, Li T, Marion B, et al.. Pilot study of mitochondrial bioenergetics in subjects with acute porphyrias. Mol Genet Metab. 2019, 128:228-35. 10.1016\/j.ymgme.2019.05.010","journal-title":"Mol Genet Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2002.01020.x","article-title":"Atypical attack of acute intermittent porphyria--paresis but no abdominal pain","volume":"252","author":"Andersson C","year":"2002","unstructured":"Andersson C, Nilsson A, B\u00e4ckstr\u00f6m T. Atypical attack of acute intermittent porphyria--paresis but no abdominal pain. J Intern Med. 2002, 252:265-70. 10.1046\/j.1365-2796.2002.01020.x","journal-title":"J Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/0004563212474555","article-title":"Best practice guidelines on clinical management of acute attacks of porphyria and their complications","volume":"50","author":"Stein P","year":"2013","unstructured":"Stein P, Badminton M, Barth J, Rees D, Stewart MF. Best practice guidelines on clinical management of acute attacks of porphyria and their complications. Ann Clin Biochem. 2013, 50:217-23. 10.1177\/0004563212474555","journal-title":"Ann Clin Biochem"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24327","article-title":"Clinical presentation and electrophysiological findings of porphyric neuropathies: a follow-up study","volume":"51","author":"Wu CL","year":"2015","unstructured":"Wu CL, Ro LS, Jung SM, et al.. Clinical presentation and electrophysiological findings of porphyric neuropathies: a follow-up study. Muscle Nerve. 2015, 51:363-9. 10.1002\/mus.24327","journal-title":"Muscle Nerve"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2020.01.361","article-title":"Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations","volume":"176","author":"Moisset X","year":"2020","unstructured":"Moisset X, Bouhassira D, Avez Couturier J, et al.. Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations. Rev Neurol (Paris). 2020, 176:325-52. 10.1016\/j.neurol.2020.01.361","journal-title":"Rev Neurol (Paris)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/BF02043962","article-title":"Possible effectiveness of plasmapheresis on the neurological complications in a case of acute intermittent porphyria","volume":"5","author":"Sit\u00e0 D","year":"1984","unstructured":"Sit\u00e0 D, Maurri S, Groppi C, Barontini F. Possible effectiveness of plasmapheresis on the neurological complications in a case of acute intermittent porphyria. Ital J Neurol Sci. 1984, 5:299-302. 10.1007\/BF02043962","journal-title":"Ital J Neurol Sci"},{"key":"ref11","article-title":"Polypeptide levels increase during acute onset of hepatic porphyrias","volume":"43","author":"Medenica R","year":"1997","unstructured":"Medenica R, Lazovic G, Huschart T, Mukerjee S, Long P, Corbitt W, Powell D. Polypeptide levels increase during acute onset of hepatic porphyrias. Cell Mol Biol (Noisy-le-grand). 1997, 43:9-27.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-9987.1997.tb00033.x","article-title":"Plasmapheresis combined with somatostatin is a successful treatment of porphyrias","volume":"1","author":"Medenica R","year":"1997","unstructured":"Medenica R, Lazovic G, Long P, Corbitt W, Powell D. Plasmapheresis combined with somatostatin is a successful treatment of porphyrias. Ther Apher. 1997, 1:159-64. 10.1111\/j.1744-9987.1997.tb00033.x","journal-title":"Ther Apher"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/172192-the-management-of-motor-neuropathy-with-plasmapheresis-in-a-patient-with-acute-porphyria-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:02:13Z","timestamp":1707508933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/172192-the-management-of-motor-neuropathy-with-plasmapheresis-in-a-patient-with-acute-porphyria-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.43196","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,9]]}}}